SOLIUS Competitors and Similar CompaniesClear all

ReShape Lifesciences's competitors and similar companies include ElectroCore and FIRE1.

	ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.	ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.	FIRE1 FIRE1 focuses on developing novel remote monitoring devices.
Founding Date	Founding Date 2002	Founding Date 2005	Founding Date N/A
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy
Locations	Locations San Clemente, US HQ San Clemente, US	Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US	Locations Dublin, IE HQ Dublin, IE
Employees	Employees 4348% decrease	Employees 5144% decrease	Employees 838% increase
Valuation ($)	Valuation ($) 3 m	Valuation ($) 71.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $11.3m (FY, 2020)	Revenue (est.) $32m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $5m (FY, 2020)	Cost of goods $4.2m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $6.3m (FY, 2020)	Gross profit $27.8m (FY, 2025)	Gross profit N/A
Net income	Net income ($21.6m) (FY, 2020)	Net income ($14m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 127m	Total funding raised $ 7.5m